e.mensa

TL2 · Recife

Contributes reviews on supplier material. Based in Recife.

Joined 18 May 2025 · last posted 2d

95 posts, newest first. Showing up to 150.

eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #41 · Clinical › Bloodwork · 26 Jul 2026 · 16 likes Understood. Thank you for being specific about the limits of it.
Reading order for a first week here, and what to skip until later — what changed since Replied, post #83 · Start Here › Welcome · 25 Jul 2026 · 0 likes The reason Reading order is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.
Common supplements people ask about, assessed one at a time Replied, post #76 · Practice › Interactions · 21 Jul 2026 · 5 likes Answering the question post #72 raises rather than the one it answers. Separation timing versus clinically important interaction: a separation timing inconvenience…
What to bring: records that a clinician can actually use — a second dataset Replied, post #55 · Clinical › Prescriber conversations · 20 Jul 2026 · 4 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #84 · Meta › Announcements · 16 Jul 2026 · 0 likes Post #82 and I disagree about the size of the effect, not about the direction. Thank you for announcing it in advance rather than after. The number of places that do…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #26 · Practice › Interactions · 14 Jul 2026 · 9 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #20 · Access › Insurance & coverage · 12 Jul 2026 · 0 likes Confirming post #17 from a second method, which matters more than confirming it from a second person. Where an exception process exists separately from an appeal, they…
Ultrasound and skinfolds: operator dependence in practice Replied, post #36 · Outcomes › Body composition · 29 Jun 2026 · 5 likes Post #33 describes the usual case. This is about the unusual one. What I want from this ultrasound and skinfolds thread is the list of things that would need to be true…
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #88 · Safety › Contraindications · 26 Jun 2026 · 0 likes Personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia type 2, is the clearest contraindication in this class and it is specific…
About the Oral incretins category Replied, post #4 · Compounds › Oral incretins · 25 Jun 2026 · 0 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #99 · Practice › Reconstitution · 9 Jun 2026 · 8 likes Post #98 put the caveat in the right place and I want to underline it. Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest…
Injecting into an area that has become firm: why not to Replied, post #40 · Practice › Administration · 9 Jun 2026 · 26 likes Noted, and I have changed what I was going to do on the strength of it.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #33 · Evidence › Journal club · 3 Jun 2026 · 3 likes I had written a reply contradicting post #29 and deleted it. Here is what survived. The honest answer on STEP 1 is that it depends, and the useful part is the list of…
Reading a trial's population section before its results Replied, post #73 · Evidence › Trials · 31 May 2026 · 2 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #107 · Compounds › Tirzepatide · 30 May 2026 · 0 likes Adding the measurement that post #104 says would settle it. A note on how Tirzepatide and nausea gets discussed rather than on Tirzepatide and nausea itself: the…
Forced degradation studies: designing one that is informative Replied, post #65 · Analytics › Method validation · 29 May 2026 · 0 likes Building on post #62 rather than restating it. A stability-indicating method is one demonstrated to resolve the analyte from its degradation products, usually through…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #20 · Compounds › Semaglutide · 8 May 2026 · 0 likes That is a cleaner way of putting what I was circling around.
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #42 · Analytics › COA interpretation · 5 May 2026 · 1 like Picking up post #39: that is the part I would want checked first. An itemised related-substances table with retention times says considerably more about the synthesis…
Reconstitution volumes that produce round numbers, tabulated Replied, post #101 · Practice › Reconstitution · 27 Apr 2026 · 7 likes Post #98 answers the question as asked. The question underneath it is different. Since reconstitution volumes keeps coming up, it should probably be a maintained page…
GLP-1 receptor distribution: central and peripheral — one year on Replied, post #7 · Pharmacology › Receptor biology · 14 Apr 2026 · 0 likes Helpful, and easy to find again, which is half of what a good reply is.
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #26 · Devices › Syringes & needles · 12 Apr 2026 · 5 likes Where I part company with post #22, and it is a narrow parting. An update on my earlier 0.3 ml versus 0.5 ml post: the pattern held for another six weeks and then…
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #16 · Analytics › Mass spectrometry · 9 Apr 2026 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #50 · Analytics › Mass spectrometry · 2 Apr 2026 · 25 likes Adding a null result on Charge states. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
Anaesthesia and elective surgery: the aspiration question Replied, post #55 · Practice › Interactions · 19 Mar 2026 · 0 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #146 · Compounds › Semaglutide · 17 Mar 2026 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
Follow-up: What a statistical analysis plan adds that the paper does not Replied, post #2 · Evidence › Trials · 24 Feb 2026 · 0 likes The figure that circulates in coverage is almost always whichever estimand gives the larger effect. That is not fraud; it is selection, and it is why the paper matters…
Reading an interaction checker output critically Replied, post #116 · Practice › Interactions · 10 Feb 2026 · 3 likes Answering the question post #112 raises rather than the one it answers. Renal or hepatic impairment changes the calculus for a lot of combinations and is the context…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #81 · Documentation › Wiki requests · 10 Feb 2026 · 7 likes Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic does not change. Worth saying I have only my own…
Foaming during reconstitution and whether it matters — the long version Replied, post #26 · Practice › Reconstitution · 5 Feb 2026 · 7 likes Agreed on Foaming during reconstitution, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and…
Cost per delivered dose, which is the number that matters Replied, post #44 · Access › Pricing · 1 Feb 2026 · 10 likes Taking post #42 at face value and following it one step further. The most useful pricing posts here are the ones that show the arithmetic rather than the conclusion.…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #26 · Pharmacology › Pharmacokinetics · 27 Jan 2026 · 29 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
Journal club: semaglutide in MASH, and surrogate endpoints — does this still hold? Replied, post #3 · marked as the solution · Evidence › Journal club · 20 Jan 2026 · 9 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #77 · Wellbeing › Mental health · 15 Jan 2026 · 21 likes Nobody has said the unglamorous part of Anxiety yet, so: most of the variation is explained by things that are boring to write about and easy to check.
Revisiting: Language barriers in accessing a prescription abroad Replied, post #36 · Access › International · 2 Jan 2026 · 6 likes Something worth flagging about Language barriers in accessing: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #106 · Compounds › Oral incretins · 23 Dec 2025 · 8 likes Coming back to post #102, because the follow-up matters more than the original answer. Why an oral formulation is a formulation achievement: the molecule is the same…
Micro-titration: a disputed topic, argued properly Replied, post #10 · Practice › Dosing & titration · 9 Dec 2025 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose. I…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #53 · Compounds › Tirzepatide · 8 Dec 2025 · 16 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #31 · Pharmacology › Pharmacokinetics · 4 Dec 2025 · 26 likes Washout after stopping takes roughly the same four to five half-lives as reaching steady state. A month after the last dose is not the same as none.
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #31 · Analytics › Impurities & related substances · 20 Nov 2025 · 2 likes Answering the question post #27 raises rather than the one it answers. Practical note on Aggregates: write down what you expect before you look. The number of times I…
High-resolution MS on aggregates and what it can see Replied, post #120 · Analytics › Mass spectrometry · 14 Nov 2025 · 0 likes On post #118 — agreed on the reasoning, with one qualification. The honest summary of what a mass result buys you: it narrows the field of what the material could be,…
Where to report an adverse event officially, by region — a second dataset Replied, post #116 · Safety › Adverse events · 10 Nov 2025 · 10 likes Post #112 describes the usual case. This is about the unusual one. Where to report: in many countries there is a pharmacovigilance system where adverse events can be…
The anatomy of a question that gets answered within an hour — the long version Replied, post #49 · Start Here › How to Ask · 1 Nov 2025 · 11 likes Do not apologise in the first line. It costs you the space where the question should be, and nobody here thinks a question is an imposition. The strength of my opinion…
New subcategory: rationale and scope Replied, post #17 · Meta › Announcements · 13 Oct 2025 · 2 likes Answering the question post #15 raises rather than the one it answers. New subcategory has been discussed here with more heat than it deserves, mostly because two…
What a regulator's shortage notice actually authorises — what changed since Replied, post #12 · Sourcing › Regulatory · 13 Oct 2025 · 8 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so.
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #103 · Analytics › HPLC & UHPLC · 11 Oct 2025 · 16 likes Resolution and tailing factor is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #76 · Practice › Reconstitution · 11 Oct 2025 · 15 likes Small correction to my own earlier position on decimal-point error. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
What a purity-only report leaves out Replied, post #42 · Sourcing › Independent verification · 10 Oct 2025 · 12 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
Sleep quality changes during weight loss — what changed since Replied, post #21 · Wellbeing › Sleep · 9 Oct 2025 · 0 likes On post #17 — agreed on the reasoning, with one qualification. A sleep diary with times rather than impressions is the only way to tell a real change from a remembered…
Publishing an inconvenient result: a case study — the long version Started this topic · Sourcing › Independent verification · 29 Sep 2025 · 2 likes Publishing an inconvenient result: a case study — the long version Writing it up because I had to work it out twice and would rather nobody else did. A narrow question…
Gauge and length selection for subcutaneous injection Replied, post #31 · Devices › Syringes & needles · 18 Sep 2025 · 1 like What I would want before treating gauge and length selection as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #139 · Data & Tools › Datasets · 11 Sep 2025 · 0 likes A codebook describing each field takes twenty minutes and is what makes the file usable by anyone but you. Most shared datasets here do not have one. The right answer…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #85 · Evidence › Journal club · 7 Sep 2025 · 5 likes A note on how orforglipron phase 2 gets discussed rather than on orforglipron phase 2 itself: the confident posts get the replies and the careful ones get ignored, and…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #24 · Data & Tools › Datasets · 7 Sep 2025 · 5 likes Date every record. A dataset assembled over two years without dates cannot distinguish a change over time from a change in who was contributing.
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #3 · Compounds › Tirzepatide · 23 Aug 2025 · 15 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #38 · Practice › Side effects · 17 Aug 2025 · 18 likes This settles it for me, at least until somebody posts a reason it should not.
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #28 · Evidence › Journal club · 13 Aug 2025 · 0 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. Worth…
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #115 · Compounds › Semaglutide · 12 Aug 2025 · 0 likes I had written a reply contradicting post #113 and deleted it. Here is what survived. The question underneath Semaglutide half-life is usually "how would I tell?" rather…
Travel coolers and how long they really hold Replied, post #78 · Devices › Cold chain · 7 Aug 2025 · 15 likes Travel with medication: carrying a vial across borders requires planning if temperatures will exceed the range or if journey time is long. Insulated travel cases with…
Coming back to: When "no data" is the complete and final answer Replied, post #60 · Compounds › Other compounds · 26 Jul 2025 · 26 likes Worth separating two things that post #56 runs together. Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry…
Appeal templates and why they are deliberately unemotional Replied, post #7 · Access › Insurance & coverage · 8 Jul 2025 · 4 likes Before the thread moves on from appeal templates — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #16 · Compounds › Cagrilintide & amylin analogues · 6 Jul 2025 · 26 likes On analysis: an amylin analogue and its aggregates are not equally detectable by a standard reversed-phase method, because a large aggregate may not elute at all. Area…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #51 · Evidence › Journal club · 15 Jun 2025 · 5 likes I read post #49 twice before replying, because I had assumed the opposite. Where the SURMOUNT-4 and continuation versus withdrawal discussion usually stalls is that…
Antibiotics and a course of something with delayed emptying Replied, post #65 · Practice › Interactions · 14 Jun 2025 · 2 likes Post #63 put the caveat in the right place and I want to underline it. Filing a mild objection to the consensus on antibiotics. Mild because I might be wrong; an…
Pregnancy as an absolute contraindication Replied, post #55 · Safety › Contraindications · 19 May 2025 · 0 likes The most common error here is treating a trial exclusion criterion as a contraindication. They are different documents with different purposes.
Validating a calculator against hand arithmetic — what changed since Replied, post #53 · Data & Tools › Calculators · 6 May 2025 · 1 like Fair, and the limits you put on it are the part I will remember.
Review: a draft on reconstitution arithmetic, with objections Replied, post #126 · Documentation › Doc review · 26 Apr 2025 · 1 like The four criteria are that the question recurs, that the content is correct and sourced or labelled as community practice, that somebody will be named as maintainer…
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #20 · Practice › Administration · 18 Apr 2025 · 17 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
Reading order for a first week here, and what to skip until later Replied, post #84 · Start Here › Welcome · 15 Apr 2025 · 0 likes Whatever the answer on reading order turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
Adjudicated events and why the definition matters — the long version Replied, post #90 · Evidence › Trials · 9 Apr 2025 · 8 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
Sequence verification for an obscure compound: how it is done Replied, post #9 · Compounds › Other compounds · 9 Apr 2025 · 27 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
Counter-ion content and its effect on measured mass Replied, post #13 · Analytics › Mass spectrometry · 8 Apr 2025 · 30 likes Post #12 describes the usual case. This is about the unusual one. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #54 · Compounds › Semaglutide · 27 Mar 2025 · 25 likes Cardiovascular data in people without diabetes is the specific contribution of SELECT, and it is worth being precise that the enrolled population had established…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #145 · Sourcing › Vendor reports · 19 Mar 2025 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
Distinguishing a deletion sequence by mass alone Replied, post #100 · Analytics › Mass spectrometry · 17 Feb 2025 · 32 likes I have been on both sides of the distinguishing a deletion sequence argument in this category within eighteen months, which should tell you how strong the evidence for…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #4 · Compounds › Semaglutide · 4 Feb 2025 · 5 likes The 2.4 mg maintenance dose in the weight-management programme and the 1.0 mg diabetes dose are frequently discussed as though they were the same drug at different…
Scheduled maintenance and what will be unavailable Replied, post #23 · Meta › Announcements · 24 Jan 2025 · 1 like Nobody has said the unglamorous part of scheduled maintenance yet, so: most of the variation is explained by things that are boring to write about and easy to check.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #14 · Practice › Reconstitution · 16 Jan 2025 · 4 likes The arithmetic in post #11 is right; the assumption feeding it is the part to check. The claim about 5 mg vial upthread is stronger than its source supports. I have…
Isotonicity and what happens when you get it wrong Replied, post #23 · Pharmacology › Formulation chemistry · 10 Jan 2025 · 4 likes A methods point on isotonicity rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #31 · Compounds › Oral incretins · 8 Jan 2025 · 20 likes Sensible. I would want the same detail before I acted on it either.
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #30 · Devices › Cold chain · 2 Jan 2025 · 0 likes Taking post #27 at face value and following it one step further. On Domestic fridge temperature mapping: the maintained page in the documentation commons covers the…
Body image changing more slowly than the body Replied, post #21 · Wellbeing › Mental health · 12 Dec 2024 · 0 likes Relationship with food changing is one of the most commonly described experiences here and is discussed far less than the physical effects. That is the version I use.…
What we do not know about retatrutide, listed explicitly Replied, post #16 · Compounds › Retatrutide · 9 Dec 2024 · 0 likes Anyone deciding on the basis of what is published should know that what is published is a phase 2 programme and some pharmacokinetics. That is a genuinely early…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #23 · Sourcing › Red flags · 6 Dec 2024 · 17 likes Nothing here should be read as an accusation against a named company, and the guidelines exist so that reports remain reports. A weak preference rather than a position.
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #66 · Clinical › Special populations · 25 Nov 2024 · 22 likes Post #63 is the version of this I will quote in future. One addition. I have been on both sides of the Type 1 diabetes argument in this category within eighteen months,…
Why "any advice?" is the least effective ending for a post Replied, post #61 · Start Here › How to Ask · 22 Nov 2024 · 22 likes Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of your working is wrong, and that is impossible if you only…
Oxidation and deamidation mass shifts, tabulated Replied, post #9 · Analytics › Mass spectrometry · 20 Nov 2024 · 0 likes An acylated peptide has a mass that reflects the modification, so comparing against the mass of the unmodified backbone gives a mismatch that is not an error.
EMA product information as a primary source — does this still hold? Replied, post #149 · Regional › European Union · 19 Nov 2024 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #88 · Compounds › Repair & healing peptides · 18 Nov 2024 · 4 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #7 · Nutrition & Training › Protein & intake · 16 Nov 2024 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
Time to steady state after a dose increase Replied, post #48 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 0 likes On post #45 — agreed on the reasoning, with one qualification. A missed weekly dose perturbs a slowly moving average rather than creating a trough. That is the…
Why our vendor pages link the storefront and mark it sponsored Replied, post #12 · Sourcing › Vendor reports · 2 Nov 2024 · 0 likes Vendor pages link the storefront is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Irish differences from the UK position Replied, post #49 · Regional › UK & Ireland · 21 Oct 2024 · 8 likes On irish differences the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Reporting a discrepancy without making an allegation Replied, post #38 · Sourcing › Vendor reports · 22 Aug 2024 · 3 likes The version of reporting a discrepancy that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Circumference measurements as a poor man's composition estimate Replied, post #66 · Outcomes › Body composition · 14 Aug 2024 · 26 likes Post #64 and I disagree about the size of the effect, not about the direction. Changes during titration: measuring body composition during active titration is less…
Assessing a warm arrival: the decision process — one year on Replied, post #126 · Sourcing › Logistics · 2 Jun 2024 · 12 likes Whatever the answer on Assessing a warm arrival turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…